Article
Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors.
mBio - 26 Sept 2017
Malet Isabelle, Subra Frédéric, Charpentier Charlotte, Collin Gilles, Descamps Diane, Calvez Vincent, Marcelin Anne-Geneviève, Delelis Olivier
Abstract excerpt
Resistance to the integrase strand transfer inhibitors raltegravir and elvitegravir is often due to well-identified mutations in the integrase gene. However, the situation is less clear for patients who fail dolutegravir treatment. Furthermore, most in vitro experiments to select resistance to dolutegravir have resulted in few mutations of the integrase gene. We performed an in vitro dolutegravir resistance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
